EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose

Magdalena Blaszkiewicz, Tianyi Tao, Kofi Mensah-Arhin, Jake W Willows, Rhiannon Bates, Wei Huang, Lei Cao, Rosemary L Smith, Kristy L Townsend

Molecular Therapy · 2024

DOI: 10.1016/j.ymthe.2024.02.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Magdalena Blaszkiewicz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Dependovirus, Obesity, Genetic Therapy, Adipocytes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maintaining functional adipose innervation is critical for metabolic health. We found that subcutaneous white adipose tissue (scWAT) undergoes peripheral neuropathy (PN) with obesity, diabetes, and aging (reduced small-fiber innervation and nerve/synaptic/growth-cone/vesicle markers, altered nerve activity). Unlike with nerve injuries, peripheral nerves do not regenerate with PN, and therefore new therapies are needed for treatment of this condition affecting 20-30 million Americans. Here, we validated a gene therapy approach using an adipocyte-tropic adeno-associated virus (AAV; serotype Rec2) to deliver neurotrophic factors (brain-derived neurotrophic factor [BDNF] and nerve growth factor [NGF]) directly to scWAT to improve tissue-specific PN as a proof-of-concept approach. AAVRec2-BDNF intra-adipose delivery improved tissue innervation in obese/diabetic mice with PN, but after longer periods of dietary obesity there was reduced efficacy, revealing a key time window for therapies. AAVRec2-NGF also increased scWAT innervation in obese mice and was more effective than BDNF, likely because Rec2 targeted adipocytes, the tissue's endogenous NGF source. AAVRec2-NGF also worked well even after 25 weeks of dietary obesity, unlike BDNF, which likely needs a vector that targets its physiological cellular source (stromal vascular fraction cells). Given the differing effects of AAVs carrying NGF versus BDNF, a combined therapy may be ideal for PN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusObesityGenetic TherapyAdipocytesGenetic VectorsSubcutaneous FatBrain-Derived Neurotrophic FactorAnimalsMiceDisease Models, AnimalNerve Growth FactorNerve Growth FactorsGene Transfer TechniquesHumansMalePeripheral Nervous System DiseasesTransduction, Genetic

Stichwörter der Autor:innen

AAVBDNFNGFadipose neuropathydiabetesdiabetic peripheral neuropathygene therapymedical devicenerve regenerationneurotrophic factors

Substanzen

Brain-Derived Neurotrophic FactorNerve Growth FactorNerve Growth Factors

Autor:innen und Institutionen

  • Department of Neurological Surgery, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210, USA.
  • College of Engineering, University of Maine, Orono, ME 04469, USA.
  • Department of Neurological Surgery, The Ohio State University, Columbus, OH 43210, USA; College of Engineering, University of Maine, Orono, ME 04469, USA. Electronic address: kristy.townsend@osumc.edu.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIDDK

Zitieren

APA

Blaszkiewicz, M., Tao, T., Mensah-Arhin, K., Willows, J. W., Bates, R., Huang, W., Cao, L., Smith, R. L., & Townsend, K. L. (2024). Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.02.035

Vancouver

Blaszkiewicz M, Tao T, Mensah-Arhin K, Willows JW, Bates R, Huang W, et al. Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.02.035

BibTeX
@article{Blaszkiewicz2024,
  author = {Blaszkiewicz, Magdalena and Tao, Tianyi and Mensah-Arhin, Kofi and Willows, Jake W and Bates, Rhiannon and Huang, Wei and Cao, Lei and Smith, Rosemary L and Townsend, Kristy L},
  title = {Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose},
  journal = {Molecular Therapy},
  year = {2024},
  doi = {10.1016/j.ymthe.2024.02.035}
}
Kostenlos starten →